The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Scientists discover how to remove skin cancer’s protective armour and stop it spreadingThe goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, ...

Sally in her garden. Credit: John Angerson Sally Steadman-South, a mother of two from Sheffield, was diagnosed with melanoma in 2014 at the age of 34, after visiting the GP about a small mole on her ...

Scientists discover how to remove skin cancer’s protective armour and stop it spreadingScientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from ...

A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.

A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients.

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Scientists have worked out how a protective element of our DNA helps prevent an abnormal genetic event that can lead to cells becoming cancerous.

ICR welcomes plans for £1 billion development to create world-leading cancer research district in SuttonThe Institute of Cancer Research has welcomed new plans to deliver around one million square ...

A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, ...